BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32514758)

  • 1. CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort.
    Jünger ST; Andreiuolo F; Mynarek M; Wohlers I; Rahmann S; Klein-Hitpass L; Dörner E; Zur Mühlen A; Velez-Char N; von Hoff K; Warmuth-Metz M; Kortmann RD; Timmermann B; von Bueren A; Rutkowski S; Pietsch T
    Acta Neuropathol; 2020 Sep; 140(3):405-407. PubMed ID: 32514758
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
    Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
    Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma.
    Zhu JJ; Jillette N; Li XN; Cheng AW; Lau CC
    Acta Neuropathol; 2020 Dec; 140(6):951-960. PubMed ID: 32909151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression.
    de Almeida Magalhães T; Cruzeiro GAV; de Sousa GR; da Silva KR; Lira RCP; Scrideli CA; Tone LG; Valera ET; Borges KS
    Cancer Gene Ther; 2020 Jun; 27(6):509-512. PubMed ID: 31308481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.
    Keenan C; Graham RT; Harreld JH; Lucas JT; Finkelstein D; Wheeler D; Li X; Dalton J; Upadhyaya SA; Raimondi SC; Boop FA; DeCuypere M; Zhang J; Vinitsky A; Wang L; Chiang J
    Acta Neuropathol; 2020 Dec; 140(6):963-965. PubMed ID: 33099686
    [No Abstract]   [Full Text] [Related]  

  • 9. Supratentorial tanycytic ependymoma.
    Richards AL; Rosenfeld JV; Gonzales MF; Ashley D; Mc Lean C
    J Clin Neurosci; 2004 Nov; 11(8):928-30. PubMed ID: 15519882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
    J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review.
    de Sousa GR; Marie SKN; Oba-Shinjo SM; Ramalho LNZ; Tone LG; Valera ET
    Childs Nerv Syst; 2019 Apr; 35(4):689-694. PubMed ID: 30631904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.
    Chavali P; Rao S; Palavalasa S; Bevinahalli N; Muthane YTC; Sadashiva N; Santosh V
    Int J Surg Pathol; 2019 May; 27(3):251-258. PubMed ID: 30251576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study.
    Wang L; Han S; Yan C; Yang Y; Li Z; Yang Z
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1259-1270. PubMed ID: 33387039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
    Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
    Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supratentorial ependymoma with YAP1:FAM118B fusion: A case report.
    Wang J; Wang L; Fu L; Li QC; Qiu XS; Wang EH; Yu JH
    Neuropathology; 2021 Apr; 41(2):133-138. PubMed ID: 33480048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report.
    Nagayasu MA; Fukushima T; Matsumoto F; Takeshima H; Sato Y; Kataoka H
    J Med Case Rep; 2022 Aug; 16(1):312. PubMed ID: 35986385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell ependymoma: a mimicker of oligodendroglioma--report of three cases.
    Jain D; Sharma MC; Arora R; Sarkar C; Suri V
    Neuropathology; 2008 Aug; 28(4):366-71. PubMed ID: 18248576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway.
    Pietsch T; Wohlers I; Goschzik T; Dreschmann V; Denkhaus D; Dörner E; Rahmann S; Klein-Hitpass L
    Acta Neuropathol; 2014 Apr; 127(4):609-11. PubMed ID: 24562983
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications.
    Chinnam D; Gupta K; Kiran T; Saraswati A; Salunke P; Madan R; Kumar N; Radotra BD
    Brain Tumor Pathol; 2022 Jul; 39(3):151-161. PubMed ID: 35348910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.